New blood test predicts who will benefit from targeted prostate cancer treatments
A new blood test could predict which men with advanced prostate cancer will respond to new targeted treatments for the disease.
May 3, 2017
0
1
A new blood test could predict which men with advanced prostate cancer will respond to new targeted treatments for the disease.
May 3, 2017
0
1
Prostate cancer cells depend on signaling through the androgen receptor (AR) to grow and survive. Many anti-cancer therapies that target ARs are initially successful in patients, including a class of drugs known as CYP17A1 ...
May 2, 2017
0
2
An orally bioavailable androgen receptor PROTAC, developed using a protein degradation technology, was effective in lowering tumor burden in mice bearing human castration-resistant prostate cancer, according to data presented ...
Apr 5, 2017
0
1
Scientists have discovered that the male androgen hormone is an important element in the ovarian development of female chicken embryos, more so than in the development of male testes.
Mar 23, 2017
0
38
A newly discovered genetic mutation that is found in a subtype of prostate cancer is integral to the disease's development and growth, according to research from Weill Cornell Medicine scientists. Their findings could pave ...
Mar 14, 2017
0
0
Failure of hormone deprivation therapy, which is used to slow prostate cancer in patients, leads to castration-resistant prostate cancer, a lethal form of advanced disease with limited treatment options.
Mar 10, 2017
0
26
A research team has studied for the first time the 3-D structure of the homodimeric androgen receptor ligand-binding domain, a structure that eluded researchers for years. This new structure of the nuclear receptor explains ...
Feb 7, 2017
0
0
An international group of researchers report success in mice of a method of using positron emission tomography (PET) scans to track, in real time, an antibody targeting a hormone receptor pathway specifically involved in ...
Nov 30, 2016
0
67
The current method of treating prostate cancer involves identifying gene defects, which could help with the diagnosis of cancer and the development of individualised cancer treatments for patients. Professor Tapio Visakorpi ...
Nov 4, 2016
0
3
Benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate, affects about half the men between 51 and 60 years of age, and nine out of 10 men older than 80. How BPH happens, however, is still open for ...
Sep 1, 2016
2
4